Low levels of β-Lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus

mBio

Volumn 3, Issue 4, 2012, Pages

  Kaplan, Jeffrey B ^a   Izano, Era A ^a   Gopal, Prerna ^a   Karwacki, Michael T ^a   Kim, Sangho ^a   Bose, Jeffrey L ^b   Bayles, Kenneth W ^b   Horswill, Alexander R ^c  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AUTOLYSIN; BACTERIAL DNA; CLOXACILLIN; DEOXYRIBONUCLEASE; EXTRACELLULAR DNA; METICILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BIOFILM; CONCENTRATION (PARAMETERS); CYTOLYSIS; DNA DETERMINATION; ENZYME INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SENSITIVE STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; DRUG EFFECT; EXTRACELLULAR SPACE; GENETICS; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BIOFILMS; DNA, BACTERIAL; EXTRACELLULAR SPACE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84865703681     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00198-12     Document Type: Article

References (42)

1. Harbarth S. 2006. Control of endemic methicillin-resistant Staphylococcus aureus-recent advances and future challenges. Clin. Microbiol. Infect. 12:1154-1162.
2. Archer NK, et al. 2011. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2:445-459.
3. Mirani ZA, Jamil N. 2011. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus. J. Basic Microbiol. 51:191-195.
4. Subrt N, Mesak LR, Davies J. 2011. Modulation of virulence gene expression by cell wall active antibiotics in Staphylococcus aureus. J. Antimicrob. Chemother. 66:979-984.
5. Haddadin RN, Saleh S, Al-Adham IS, Buultjens TE, Collier PJ. 2010. The effect of subminimal inhibitory concentrations of antibiotics on virulence factors expressed by Staphylococcus aureus biofilms. J. Appl. Microbiol. 108:1281-1291.
6. Frank KL, Reichert EJ, Piper KE, Patel R. 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 51:888-895.
7. Kaplan JB. 2011. Antibiotic-induced biofilm formation. Int. J. Artif. Organs 34:737-751.
8. Carsenti-Etesse H, et al. 1992. Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence of Staphylococcus aureus and Staphylococcus epidermidis to polystyrene culture plates. Eur. J. Clin. Microbiol. Infect. Dis. 11:732-737.
9. Carsenti-Etesse H, et al. 1993. Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob. Agents Chemother. 37:921-923.
10. Odenholt I. 2001. Pharmacodynamic effects of subinhibitory antibiotic concentrations. Int. J. Antimicrob. Agents 17:1-8.
11. Smith DL, Harris AD, Johnson JA, Silbergeld EK, Morris JG, Jr. 2002. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc. Natl. Acad. Sci. U. S. A. 99:6434-6439.
12. Izano EA, Amarante MA, Kher WB, Kaplan JB. 2008. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl. Environ. Microbiol. 74:470-476.
13. Kaplan JB, et al. 2012. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. J. Antibiot. (Tokyo) 65:73-77.
14. Pozzi C, et al. 2012. Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog. 8:e1002626.
15. Heilmann C. 2011. Adhesion mechanisms of staphylococci. Adv. Exp. Med. Biol. 715:105-123.
16. Mann EE, et al. 2009. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One 4:e5822.
17. Rice KC, et al. 2007. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 104:8113-8118.
18. Houston P, Rowe SE, Pozzi C, Waters EM, O'Gara JP. 2011. Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect. Immun. 79:1153-1165.
19. Boles BR, Horswill AR. 2008. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4:e1000052.
20. Kiedrowski MR, et al. 2011. Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS One 6:e26714.
21. Kaplan JB, Jabbouri S, Sadovskaya I. 2011. Extracellular DNAdependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics. Res. Microbiol. 162:535-541.
22. Pérez-Giraldo C, et al. 1994. In-vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin. J. Antimicrob. Chemother. 33:845-848.
23. Calabrese EJ, Baldwin LA. 2001. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol. Sci. 22:285-291.
24. Tsang LH, Cassat JE, Shaw LN, Beenken KE, Smeltzer MS. 2008. Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One 3:e3361.
25. Herbert S, et al. 2007. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3:e102.
26. Bisognano C, Vaudaux PE, Lew DP, Ng EY, Hooper DC. 1997. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 41:906-913.
27. Merino N, et al. 2009. Protein A-mediated multicellular behavior in Staphylococcus aureus. J. Bacteriol. 191:832-843.
28. Singh R, Ray P, Das A, Sharma M. 2010. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 65:1955-1958.
29. Marshall BM, Levy SB. 2011. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 24:718-733.
30. Bose JL, Lehman MK, Fey PD, Bayles KW. Contribution of the Staphylococcus aureus AtlA AM and GL murein hydrolase activities in cell division, autolysis, and biofilm formation. PLoS One, in press.
31. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146.
32. Baba T, et al. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
33. Duthie ES, Lorenz LL. 1952. Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6:95-107.
34. Diep BA, et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739.
35. Kuroda M, et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
36. Holden MT, et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 101:9786-9791.
37. Gill SR, et al. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187:2426-2438.
38. Herron LL, et al. 2002. Genome sequence survey identifies unique sequences and key virulence genes with unusual rates of amino acid substitution in bovine Staphylococcus aureus. Infect. Immun. 70:3978-3981.
39. Eleaume H, Jabbouri S. 2004. Comparison of two standardisation methods in real-time quantitative RT-PCR to follow Staphylococcus aureus genes expression during in vitro growth. J. Microbiol. Methods 59: 363-370.
40. Horsburgh MJ, et al. 2002. σB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J. Bacteriol. 184:5457-5467.
41. Shanks RM, et al. 2005. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 73:4596-4606.
42. Jonsson P, Lindberg M, Haraldsson I, Wadström T. 1985. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect. Immun. 49:765-769.